Drug Shortage Report for MIFEGYMISO

Last updated on 2022-11-24 History
Report ID 175501
Drug Identification Number 02444038
Brand name MIFEGYMISO
Common or Proper name Mifepristone/Misoprostol
Company Name LINEPHARMA INTERNATIONAL LIMITED
Market Status MARKETED
Active Ingredient(s) MISOPROSTOL MIFEPRISTONE
Strength(s) 200MCG 200MG
Dosage form(s) TABLET KIT
Route of administration ORAL BUCCAL ORAL BUCCAL
Packaging size Combipack - 1 box with 1 tablet of mifepristone 200mg tablet + 1 box with 4 tablets of 200mcg misoprostol
ATC code G03XB
ATC description OTHER SEX HORM. & MODULATORS OF THE GENITAL SYSTEM
Reason for shortage Delay in shipping of the drug.
Anticipated start date 2022-11-23
Actual start date 2022-11-23
Estimated end date 2022-12-05
Actual end date
Shortage status Actual shortage
Updated date 2022-11-24
Company comments Linepharma International Limited considers that this shortage situation has a very low impact on public health since there are product available for patients through wholesalers. Moreover, more product is due to be made available during the first week of December 2022.
Health Canada comments
Tier 3 Status No
Contact Address 16 UPPER WOBURN PLACE
LONDON, GREATER LONDON
UNITED KINGDOM WC1H0BS
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2022-11-23 English Compare
v2 2022-11-23 English Compare
v3 2022-11-23 English Compare
v4 2022-11-23 French Compare
v5 2022-11-24 English Compare

Showing 1 to 5 of 5